Clinical Trials in San Antonio

Showing 1581-1600 of 7,028 trials

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

NCT07122700

The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance the regulatory qualification of blood- and imaging-based biomarkers to diagnose and stage Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH). MASH is characterized by liver inflammation accompanied by simultaneous fat accumulation in the liver.

Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, Liver+5 more

Foundation for the National Institutes of Health400 participantsStarted May 2025

Miami, Florida, United States • Columbus, Ohio, United States • Bellaire, Texas, United States +1 more locations

Enrolling By Invitation< 1 mile

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

NCT06208878

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

Hematologic MalignancySolid Malignancy

CRISPR Therapeutics AG70 participantsStarted Nov 2023

Duarte, California, United States • Los Angeles, California, United States • Stanford, California, United States +19 more locations

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Find Trials by Condition in San Antonio

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Treatment for PTSD and Tinnitus

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Topical ENS-002 for Atopic Dermatitis in Adults

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Expanded Access of Sotorasib

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours